Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DPII: Discovery Partners Int'l -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (28)	10/22/2005 3:03:32 PM
From: tuck	Read Replies (1) \| Respond to of 111

As you may know, I used to follow DPII pretty closely in the Trickle Portfolio thread. Now I just wait for the price to recover for some reason and so I can sell, without paying it any attention. I'm disappointed in the slow development of the uARCS system. It's probably dead now, as I think other screening technologies may have caught up to it. It seemed as though it could be pretty cheap, though. Anyhow, I was looking for it to be on the market a year or two ago. I can't remember what DPII paid Abbott for this. The nanokan seemed pretty cool, too. I saw one at the Lab Automation in Palm Springs a few years ago. Like Argonaut's automated chemistry products, this seemed like a marketable technology, but never caught on. There's still a bit of DPII in my Mom's portfolio. I don't have much hope for these guys now. Too much stuff never got developed or sold, so I am leery of management's execution in anything but contract chemistry. Next time they get a good burst of business in that area, causing the stock to get over $4 -- if ever -- I'm getting out. Good Luck to both of us! Cheers, Tuck